Percutaneous Dilatational Tracheostomy in Critically Ill Patients Taking Antiplatelet Agents
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Percutaneous dilatational tracheostomy (PDT) has been considered as an alternative to surgical tracheostomy in intensive care units (ICU), and is widely used for critically ill patients who need prolonged mechanical ventilation. Few studies have reported on PDT performed in critically ill patients taking antiplatelet agents. Our goals are to assess not only the feasibility and safety of PDT, but also bleeding complications in the patients receiving such therapy. Methods: In a single institution, PDTs were performed by pulmonologists at the medical ICU bedside using the single tapered dilator technique and assisted by flexible bronchoscopy to confirm a secure puncture site. From March 2011 to February 2013, the patients’ demographic and clinical data, procedural parameters, outcomes and complications were analyzed and compared complications between patients taking antiplatelet agents and those not. Results: PDTs were performed for 138 patients; the median age was 72 years, mean body mass index was 20.3 ± 4.8 kg/m 2 , and mean acute physiology and chronic health evaluation II score was 24.4 ± 9.4. Overall, the procedural success rate was 100% and the total procedural time was 25 ± 8.5 min. There were no periprocedural life-threatening complications, and no statistical difference in the incidence of bleeding complications between patients who had taken antiplatelet agents and those had not (p = 0.657). Conclusions: PDT performed in critically ill patients taking antiplatelet agents was a feasible procedure and was implemented without additional bleeding complications.
Abstract
Background: Percutaneous dilatational tracheostomy (PDT) has been considered as an alternative to surgical tracheostomy in intensive care units (ICU), and is widely used for critically ill patients who need prolonged mechanical ventilation. Few studies have reported on PDT performed in critically ill patients taking antiplatelet agents. Our goals are to assess not only the feasibility and safety of PDT, but also bleeding complications in the patients receiving such therapy. Methods: In a single institution, PDTs were performed by pulmonologists at the medical ICU bedside using the single tapered dilator technique and assisted by flexible bronchoscopy to confirm a secure puncture site. From March 2011 to February 2013, the patients’ demographic and clinical data, procedural parameters, outcomes and complications were analyzed and compared complications between patients taking antiplatelet agents and those not. Results: PDTs were performed for 138 patients; the median age was 72 years, mean body mass index was 20.3 ± 4.8 kg/m 2 , and mean acute physiology and chronic health evaluation II score was 24.4 ± 9.4. Overall, the procedural success rate was 100% and the total procedural time was 25 ± 8.5 min. There were no periprocedural life-threatening complications, and no statistical difference in the incidence of bleeding complications between patients who had taken antiplatelet agents and those had not (p = 0.657). Conclusions: PDT performed in critically ill patients taking antiplatelet agents was a feasible procedure and was implemented without additional bleeding complications.
참고문헌 (20)
- Shelden CH, "A new method for tracheotomy", J Neurosurg, 12, pp.428~431 (1955)
- Seldinger SI, "Catheter replacement of the needle in percutaneous arteriography; a new technique", Acta radiol, 39, pp.368~376 (1953)
- Ciaglia P, "Elective percutaneous dilatational tracheostomy. A new simple bedside procedure; preliminary report", Chest, 87, pp.715~719 (1985)
- Freeman BD, "A prospective, randomized study comparing percutaneous with surgical tracheostomy in critically ill patients", Crit Care Med, 29, pp.926~930 (2001)
- Delaney A, "Percutaneous dilatational tracheostomy versus surgical tracheostomy in critically ill patients: a systematic review and meta-analysis", Crit Care, 10, pp.R55~ (2006)
- Friedman Y, "Comparison of percutaneous and surgical tracheostomies", Chest, 110, pp.480~485 (1996)
- Krishnan K, "The current practice of tracheostomy in the United Kingdom: a postal survey", Anaesthesia, 60, pp.360~364 (2005)
- Kluge S, "Tracheostomy in the intensive care unit: a nationwide survey", Anesth Analg, 107, pp.1639~1643 (2008)
- Veenith T, "Intensive care unit tracheostomy: a snapshot of UK practice", Int Arch Med, 1, pp.21~ (2008)
- Abouzgheib W, "Percutaneous dilational tracheostomy in patients receiving antiplatelet therapy: is it safe?", J Bronchology Interv Pulmonol, 20, pp.322~325 (2013)
- Massick DD, "Quantification of the learning curve for percutaneous dilatational tracheotomy", Laryngoscope, 110(2 Pt 1), pp.222~228 (2000)
- 유홍석, "내과계 중환자실 전담의에 의해 시행된 경피적 확장 기관절개술의 안정성 및 유용성", 대한중환자의학회지, 26(4), pp.261~266 (2011), 대한중환자의학회
- 이대상, "Safety and Feasibility of Percutaneous Dilatational Tracheostomy Performed by Intensive Care Trainee", The Korean Journal of Critical Care Medicine, 29(2), pp.64~69 (2014), 대한중환자의학회[DOI]
- Grant CA, "Tracheo-innominate artery fistula after percutaneous tracheostomy:three case reports and a clinical review", Br J Anaesth, 96, pp.127~131 (2006)
- Al-Ansari MA, "Clinical review: percutaneous dilatational tracheostomy", Crit Care, 10, pp.202~ (2006)
- Flint AC, "Bedside ultrasound screening for pretracheal vascular structures may minimize the risks of percutaneous dilatational tracheostomy", Neurocrit Care, 11, pp.372~376 (2009)
- Rudas M, "Safety and efficacy of ultrasonography before and during percutaneous dilatational tracheostomy in adult patients: a systematic review", Crit Care Resusc, 14, pp.297~301 (2012)
- Al Dawood A, "The safety of percutaneous tracheostomy in patients with coagulopathy or thrombocytopenia", Middle East J Anesthesiol, 19, pp.37~49 (2007)
- Kluge S, "Percutaneous tracheostomy is safe in patients with severe thrombocytopenia", Chest, 126, pp.547~551 (2004)
- Kost KM, "Endoscopic percutaneous dilatational tracheotomy:a prospective evaluation of 500 consecutive cases", Laryngoscope, 115(10 Pt 2), pp.1~30 (2005)